Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Judge Determines Monsanto Should Pay More Than $25M to Man Diagnosed with Non-Hodgkins Lymphoma from Roundup July 16, 2019 Austin Kirk Add Your Comments The U.S. District Judge presiding over all federal Roundup lawsuits has determined that Monsanto should pay more than $25 million of the damages awarded in the first bellwether trial, rejecting the manufacturer’s request for a new trial. He also upheld the full amount of compensatory damages awarded by the jury and a substantial portion of the original $75 million in punitive damages designed to punish Monsanto for failing to warn about the risk that their weedkiller may cause non-Hodgkins lymphoma. In March 2019, a federal jury originally awarded a combined $80 million in damages to Edwin Hardeman, who was diagnosed with non-Hodgkins lymphoma caused by Roundup. The initial verdict included more than $5 million in compensatory damages, as well as an additional award of punitive damages that were nearly 15 times that amount. While Monsanto argued that the entire verdict should be thrown out, U.S. District Judge Vince Chhabria issued an order (PDF) on July 15, finding that the evidence presented at trial supported the full award compensatory damages returned by the jury, meaning that a new trial was not necessary. However, the court determined that constitutional caps on the size of punitive damages required that portion of the award to be reduced to $20 million, or roughly four times the amount of the compensatory damages. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “It is easy to uphold the award of past noneconomic damages. Mr. Hardeman presented substantial evidence of his past emotional and physical suffering, including the terror of being diagnosed with non-Hodgkin’s lymphoma, the uncertainty surrounding his long-term prognosis, and the debilitating effects of chemotherapy. There is no basis for questioning the jury’s valuation of that suffering,” according to the order. Judge Chhabria also found that the damages awarded for future suffering are “within the realm of rationality”, recognizing that the award included roughly $750,000 for each past year and roughly $130,00 for each future year. “Recognizing that pain and suffering are inherently hard to quantify, the jury could reasonably conclude that Mr. Hardeman’s ongoing fear and anxiety warrants an award that, while significant, is still materially lower on an annual basis than his award for past harm,” Judge Chhabria wrote in the eight page order. Monsanto also argued that the punitive damages awarded by the jury were not supported by the evidence, which Judge Chhabria also rejected in language that highlights the liability exposure the manufacturer may face at trial in thousands of other cases that are still awaiting trial dates. “Based on the evidence that came in at trial, Monsanto deserves to be punished,” according to the order. “As relevant here, California law provides for an award of punitive damages where the defendant acted with malice, meaning either ‘conduct which [was] intended by the defendant to cause injury to the plaintiff’ or ‘despicable conduct which [was] carried on by the defendant with a willful and conscious disregard of the rights or safety of others.’ It was reasonable for the jury to put Monsanto’s behavior in the latter category, because the evidence easily supported a conclusion that Monsanto was more concerned with tamping down safety inquiries and manipulating public opinion than it was with ensuring its product is safe.” While supporting punitive damages in the case, Judge Chhabria did determine that the size of the jury award exceeded constitutional limits under the Due Process Clause. Judge Chhabria acknowledged that Monsanto’s conduct involving the development and sale of Roundup was “reprehensible”, but indicated that it did not support a punitive damage award at the magnitude of approximately 15 times the amount of compensatory damages. Guided by the conduct of Monsanto demonstrated at trial, Judge Chhabria found that a punitive damage award of $20 million — roughly four times the amount of compensatory damages — is the maximum award that is constitutionally permissible in this case. The decision substantially increases the pressure on Monsanto and its parent company, Bayer, to negotiate Roundup settlements to resolve more than 15,000 cases pending nationwide, as nearly identical evidence will be presented in each case, and the company could face devastating punitive damage awards in a large number of additional cases if the litigation is not resolved. In addition to Hardeman’s trial, two other Roundup cases have gone to trial in California state court, each also resulting in massive compensatory and punitive damage awards for the plaintiffs. The repeated losses at trial have been viewed as compelling evidence about how other juries are likely to respond to similar evidence that is likely to be repeated throughout each of the cases. Last summer, the first Roundup trial resulted in a $289 million jury verdict for a former school groundskeeper diagnosed with non-Hodgkins lymphoma. Under California law, the damages in that Roundup case were subsequently reduced to $78 million, which both Monsanto and the plaintiffs are each appealing. Following the Hardeman verdict in March 2019, a third trial ended in May with a landmark $2 billion verdict in California state court, involving compensatory and punitive damages awarded to a husband and wife who were each diagnosed with non-Hodgkins lymphoma following use of Roundup. Judge Chhabria has previously suggested that if the litigation is not resolved, large numbers of individual cases will be remanded back to U.S. District Courts for individual trial dates next year. To facilitate potential settlement of the cases and help guide the parties toward fair offers for damages in each Roundup case, Judge Chhabria has ordered the parties to participate in a mediation process with prominent attorney Ken Feinberg, who has been involved in some of the largest settlements in high-profile litigation in recent years, including funds to pay claims related to the BP oil spill, Volkswagen emissions scandal, General Motors ignition switch recall, September 11th Victim Compensation fund and others. The next federal bellwether trial before Judge Chhabria is scheduled to begin in February 2020, with additional state court cases expected to go before juries in Missouri later this year. Tags: Bayer, Cancer, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial July 25, 2025 New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: today) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: yesterday) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025) Student Social Media Addiction Lawsuits Brought by School Districts Will Be First MDL Bellwether Trials (Posted: 2 days ago) Claims that allege social media platforms are intentionally designed to cause addiction in students will be the first federal lawsuits to go before juries. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITRoblox Kidnapping Lawsuit Filed After Child Was Abducted and Sex Trafficked (09/03/2025)ChatGPT Wrongful Death Lawsuit Claims AI Helped Teen Commit Suicide (08/28/2025)TikTok’s Addictive Algorithms Prey on Teens, Contributing to Student Mental Health Issues: Lawsuit (08/26/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: today) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: yesterday) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Student Social Media Addiction Lawsuits Brought by School Districts Will Be First MDL Bellwether Trials (Posted: 2 days ago) Claims that allege social media platforms are intentionally designed to cause addiction in students will be the first federal lawsuits to go before juries. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITRoblox Kidnapping Lawsuit Filed After Child Was Abducted and Sex Trafficked (09/03/2025)ChatGPT Wrongful Death Lawsuit Claims AI Helped Teen Commit Suicide (08/28/2025)TikTok’s Addictive Algorithms Prey on Teens, Contributing to Student Mental Health Issues: Lawsuit (08/26/2025)